M. Hatton

Weston Park Cancer Centre — United Kingdom

Medicine · Health Sciences

35h-index6.7kcitations261works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(114), Lung Cancer Treatments and Mutations(74), Advanced Radiotherapy Techniques(56), Lung Cancer Research Studies(48), Atomic and Subatomic Physics Research(26)

Publications259 total

263 The DAHRTS Study- Durvalumab after concurrent chemotherapy and accelerated high-dose twice-daily thoracic radiotherapy in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Lung Cancer·2026
210 Radical radiotherapy for non-small cell lung cancer (NSCLC): A single-centre, 10-year retrospective comparison of outcomes for two accelerated fractionation schedules
Lung Cancer·2026
Establishing a National SABR Service: A Model for Safe and Effective Clinical Implementation
Clinical Oncology·2025· 1 cited
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer
New England Journal of Medicine·2025· 8 citedOpen Access
Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer
Journal of Thoracic Oncology·2025· 1 cited
1890 ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer. (ISRCTN47674500)
Radiotherapy and Oncology·2025
3513 ATM inhibition with AZD1390 and conventional radiotherapy in non-small cell lung cancer: interim report from the CONCORDE phase Ib trial (NCT04550104)
Radiotherapy and Oncology·2025
471 Quality of Life after post mastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year followup results of a prospective randomised trial.
Radiotherapy and Oncology·2025
When Complexity Meets Complexity: <scp>COVID</scp>‐19‐Induced Supply Chain Disruptions and Strategy Portfolio Efficiency
Journal of Operations Management·2024· 11 citedOpen Access
Palliative Radiotherapy Practice in Lung Cancer: Time to Advance?
Clinical Oncology·2024Open Access
Olaparib, AZD1390, ceralasertib, saruparib and consolidation durvalumab (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2024
1048: Cardiac SABR for Ventricular Tachycardia – UK experience of safety and efficacy
Radiotherapy and Oncology·2024
2500: Interim results of the prospective RTQA procedures for HALT (CRUK/16/, EORTC 1702-LCG-ROG)
Radiotherapy and Oncology·2024
1614: MRI V/Q for assessing radiation-induced changes in regional lung function in lung cancer patients
Radiotherapy and Oncology·2024
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm
Radiotherapy and Oncology·2024
1596: The impact of dosimetric features on interpretable overall survival prediction in NSCLC radiotherapy
Radiotherapy and Oncology·2024
209 ThOracic Umbrella RadIotherapy STudy in stage IV NSCLC: TOURIST
Lung Cancer·2024· 1 cited
Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy
Radiotherapy and Oncology·2024· 13 citedOpen Access
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis
The Lancet Oncology·2023· 50 citedOpen Access
P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC
Journal of Thoracic Oncology·2023· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Corinne Faivre‐Finn(11), Jim M. Wild(9), Rob H. Ireland(8), Ben J. Slotman(7), Suresh Senan(7), Matthew Winter(7), Bilal Tahir(6), Kieran Horgan(6), Chris Holcombe(6), Lynda Wyld(6), Jenna Morgan(5), Karen Collins(5), Sue Ward(5), Geoffrey R. Holmes(5), Mike Bradburn(5), Stephen J. Walters(5), Maria Burton(5), Kate Lifford(5), Adrian Edwards(5), Thompson Robinson(5)